119 related articles for article (PubMed ID: 36779309)
1. Participation in breast cancer screening and its influence on other cancer screening invitations: study in women aged 56 years old in four French departments.
Poiseuil M; Moutel G; Cosson M; Quertier MC; Duchange N; Darquy S
Eur J Cancer Prev; 2023 May; 32(3):238-245. PubMed ID: 36779309
[TBL] [Abstract][Full Text] [Related]
2. How do women comply with cancer screenings? A study in four regions of France.
Duchange N; Poiseuil M; Rollet Q; Piette C; Cosson M; Quertier MC; Moutel G; Darquy S
BMC Womens Health; 2023 Apr; 23(1):190. PubMed ID: 37085818
[TBL] [Abstract][Full Text] [Related]
3. Concurrent participation in breast, cervical, and colorectal cancer screening in the Netherlands.
Kregting LM; Olthof EMG; Breekveldt ECH; Aitken CA; Heijnsdijk EAM; Toes-Zoutendijk E; de Koning HJ; van Ravesteyn NT
Eur J Cancer; 2022 Nov; 175():180-186. PubMed ID: 36126478
[TBL] [Abstract][Full Text] [Related]
4. Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
Bertaut A; Coudert J; Bengrine L; Dancourt V; Binquet C; Douvier S
PLoS One; 2018; 13(6):e0198939. PubMed ID: 29927995
[TBL] [Abstract][Full Text] [Related]
5. Cervical and breast cancer screening participation for women with chronic conditions in France: results from a national health survey.
Constantinou P; Dray-Spira R; Menvielle G
BMC Cancer; 2016 Mar; 16():255. PubMed ID: 27029643
[TBL] [Abstract][Full Text] [Related]
6. Predictive factors for non-participation or partial participation in breast, cervical and colorectal cancer screening programmes†.
Dawidowicz S; Le Breton J; Moscova L; Renard V; Bercier S; Brixi Z; Audureau E; Clerc P; Bastuji-Garin S; Ferrat E
Fam Pract; 2020 Feb; 37(1):15-24. PubMed ID: 31305884
[TBL] [Abstract][Full Text] [Related]
7. Temporal trend in socioeconomic inequalities in the uptake of cancer screening programmes in France between 2005 and 2010: results from the Cancer Barometer surveys.
Kelly DM; Estaquio C; Léon C; Arwidson P; Nabi H
BMJ Open; 2017 Dec; 7(12):e016941. PubMed ID: 29247085
[TBL] [Abstract][Full Text] [Related]
8. Organised screening for cervical cancer in France: a cost-effectiveness assessment.
Barré S; Massetti M; Leleu H; De Bels F
BMJ Open; 2017 Oct; 7(10):e014626. PubMed ID: 28988162
[TBL] [Abstract][Full Text] [Related]
9. Women's participation in breast cancer screening in France--an ethical approach.
Moutel G; Duchange N; Darquy S; de Montgolfier S; Papin-Lefebvre F; Jullian O; Viguier J; Sancho-Garnier H;
BMC Med Ethics; 2014 Aug; 15():64. PubMed ID: 25127662
[TBL] [Abstract][Full Text] [Related]
10. Survival after breast cancer according to participation in organised or opportunistic screening and deprivation.
Poiseuil M; Payet C; Molinié F; Dabakuyo-Yonli TS; Mathoulin-Pelissier S; Amadeo B; Coureau G
Cancer Epidemiol; 2023 Feb; 82():102312. PubMed ID: 36508966
[TBL] [Abstract][Full Text] [Related]
11. Social disparities in access to breast and cervical cancer screening by women living in Spain.
Ricardo-Rodrigues I; Jiménez-García R; Hernández-Barrera V; Carrasco-Garrido P; Jiménez-Trujillo I; López de Andrés A
Public Health; 2015 Jul; 129(7):881-8. PubMed ID: 25818014
[TBL] [Abstract][Full Text] [Related]
12. [Breast cancer screening in thirteen French departments].
Ouédraogo S; Dabakuyo-Yonli TS; Roussot A; Dialla PO; Pornet C; Poillot ML; Soler-Michel P; Sarlin N; Lunaud P; Desmidt P; Paré E; Mathis C; Rymzhanova R; Kuntz-Huon J; Exbrayat C; Bataillard A; Régnier V; Kalecinski J; Quantin C; Dumas A; Gentil J; Amiel P; Chauvin F; Dancourt V; Arveux P
Bull Cancer; 2015 Feb; 102(2):126-38. PubMed ID: 25636359
[TBL] [Abstract][Full Text] [Related]
13. Factors contributing to the low participation rate of Turkish women to a breast cancer screening program in Antwerp, Belgium.
Topal F; Van Roosbroeck S; Van Hal G; Jacquemyn Y
Eur J Gynaecol Oncol; 2015; 36(5):520-3. PubMed ID: 26513875
[TBL] [Abstract][Full Text] [Related]
14. Mammography screening for breast cancer in Copenhagen April 1991-March 1997. Mammography Screening Evaluation Group.
Lynge E
APMIS Suppl; 1998; 83():1-44. PubMed ID: 9850674
[TBL] [Abstract][Full Text] [Related]
15. Mammography service screening and breast cancer mortality in New Zealand: a National Cohort Study 1999-2011.
Morrell S; Taylor R; Roder D; Robson B; Gregory M; Craig K
Br J Cancer; 2017 Mar; 116(6):828-839. PubMed ID: 28183141
[TBL] [Abstract][Full Text] [Related]
16. Determinants of cancer screening awareness and participation among Indonesian women.
Anwar SL; Tampubolon G; Van Hemelrijck M; Hutajulu SH; Watkins J; Wulaningsih W;
BMC Cancer; 2018 Mar; 18(1):208. PubMed ID: 29506486
[TBL] [Abstract][Full Text] [Related]
17. Irregular screening participation increases advanced stage breast cancer at diagnosis: A population-based study.
Ding L; Greuter MJW; Truyen I; Goossens M; De Schutter H; de Bock GH; Van Hal G
Breast; 2022 Oct; 65():61-66. PubMed ID: 35820298
[TBL] [Abstract][Full Text] [Related]
18. [Knowledge of women and men about breast cancer prevention].
Najdyhor E; Krajewska-Kułak E; Krajewska-Ferishah K
Ginekol Pol; 2013 Feb; 84(2):116-25. PubMed ID: 23668058
[TBL] [Abstract][Full Text] [Related]
19. Screening for breast and cervical cancer in a large German city: participation, motivation and knowledge of risk factors.
Klug SJ; Hetzer M; Blettner M
Eur J Public Health; 2005 Feb; 15(1):70-7. PubMed ID: 15788807
[TBL] [Abstract][Full Text] [Related]
20. Comparing barriers to colorectal cancer screening with barriers to breast and cervical screening: a population-based survey of screening-age women in Great Britain.
Lo SH; Waller J; Wardle J; von Wagner C
J Med Screen; 2013 Jun; 20(2):73-9. PubMed ID: 23761420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
